Lien studied pharmaceutical sciences where she focused on targeted cancer therapy in her master thesis. After her studies, she did an IWT-funded PhD in the lab of Biopharmaceutical Technology of Prof. Bruno De Geest at Ghent University where she focused on the design of immune-modulating generic polymeric strategies for personalized cell-based cancer vaccination.
During her PhD she went abroad as FWO-funded visiting researcher in the lab of Prof. Aaron Esser-Kahn at the University of California, Irvine where she researched TLR-ligand adjuvant functionalization of cancer vaccines. She published seven first-author A1 publications and is co-author on multiple different scientific papers.
Lien has profound expertise in the immune-oncology field and in-depth knowledge of tumor immuno-biology and therapeutic strategies, As CDO, Lien leads the camyotopeTM drug development department of myNEO Therapeutics.